Stocks›Healthcare
WatchAlert

Rubicon Research Limited

RUBICON · NSE · Healthcare · As of 8 Nov 2026
₹1,730.80
+₹71.50 (+4.31%)(1D)
₹609.2552 Week Range₹1,899.00
Market Cap
₹28,573 Cr
P/E (Sector)
87.8 (32.3)
P/B Ratio
22.17
Dividend Yield
0.09%
ROE
19.1%
Debt / Equity
0.20
Anvest Score
62/100
  • Valuation
    0
  • Quality
    85
  • Growth
    49
  • Health
    95
  • Momentum
    94
Loading company profile…

Fundamentals

P/E Ratio (TTM)
87.77
Sector median P/E
32.29
P/B Ratio
22.17
Sector median P/B
4.4
EPS (TTM)
₹19.72
Market Cap
₹28,573 Cr
Dividend Yield
0.09%
ROE
19.14%
ROCE
23.43%
Profit Margin
14.01%
Debt/Equity
0.2
Current Ratio
2.01
Interest Coverage
8.6
Book Value
₹78.07
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

Rubicon Research Limited FAQs

3 topics
Expand
What does the Rubicon Research Limited (RUBICON) stock page cover?
Rubicon Research Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for RUBICON?
Rubicon Research Limited is currently shown with a delayed price near ₹1,730.8, P/E 87.77, and ROE 19.14%.
Does the RUBICON page provide investment advice?
No. The RUBICON page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights